- UroToday Home
- Recent Abstracts
- Pelvic Health & Reconstruction
Overactive Bladder
Factors Associated with Therapeutic Efficacy of Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Syndrome
February 1, 2016
Impact of daily number of urgency urinary incontinence episodes on overactive bladder patient reported outcomes
January 27, 2016
Discovery of Vibegron: A Potent and Selective Beta 3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder
December 31, 2015
The Impact of Dry Mouth on Fluid Intake and Overactive Bladder Symptoms in Women taking Fesoterodine
December 29, 2015
Potential benefits of diagnosis and treatment on health outcomes among elderly people with symptoms of overactive bladder
December 28, 2015
The use of biomarkers in the diagnosis and treatment of overactive bladder: Can we predict the patients who will be resistant to treatment?
December 28, 2015
Urinary tract infections in women with urogynaecological symptoms
December 23, 2015
Delivery methods for drugs used in the treatment of overactive bladder
December 23, 2015
Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada
December 15, 2015
Persistence and concomitant medication in patients with overactive bladder treated with antimuscarinic agents in primary care. An observational baseline study
November 17, 2015
Are urge incontinence and aging risk factors of erectile dysfunction in patients with male lower urinary tract symptoms?
November 17, 2015
Does Increasing or Decreasing the Daily Intake of Water/Fluid by Adults Affect Overactive Bladder Symptoms?
November 11, 2015
Effect of Tamsulosin in Lower Urinary Tract Symptom Patients with Metabolic Syndrome
November 10, 2015